Impact Factor 5.555 | CiteScore 5.1
More on impact ›
Indexed in: Chemical Abstracts Service (CAS), CLOCKSS, CrossRef, DOAJ, EBSCO, Embase, Google Scholar, MEDLINE, OpenAIRE, PubMed, PubMed Central (PMC), Scopus, Semantic Scholar, Ulrich's Periodicals Directory, Web of Science Science Citation Index Expanded (SCIE), Zetoc
PMCID: all published articles receive a PMCID
Cancer Endocrinology welcomes submissions of the following article types: Case Report, Clinical Trial, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Policy and Practice Reviews, Review, Study Protocol, Systematic Review and Technology and Code.
All manuscripts must be submitted directly to the section Cancer Endocrinology, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact firstname.lastname@example.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact email@example.com